References
- HuangEBasuAO’GradyMCaprettaJProjecting the future diabetes population size and related costs for the U.SDiabetes Care200932122225222919940225
- JeffcoateWJMacfarlaneRMThe Diabetic Foot: An Illustrated Guide to ManagementLondonChapman and Hall Medical1995
- JeffcoateWJHardingKGDiabetic foot ulcersLancet200336193681545155112737879
- WildSRoglicGGreenASicreeRKingHGlobal prevalence of diabetes: estimates for the year 2000 and projections for the year 2030Diabetes Care20042751047105315111519
- SinghNArmstrongDLipskyBPreventing foot ulcers in patients with diabetesJAMA2005293221722815644549
- PathareNBalATalvalkarGAntaniDDiabetic foot infections: a study of microorganism associated with the different Wagner gradesIndian J Pathol Microbiol19984144374419866905
- FrykbergRDiabetic foot ulcers: pathogenesis and managementAm Fam Physician20026691655166212449264
- WagnerFWJrThe diabetic footOrthopedics19871011631723809012
- CalhounJHCantrellJCobosJTreatment of diabetic foot infections: Wagner classification, therapy, and outcomeFoot Ankle1988931011063229695
- EckmanMHGreenfieldSMackeyWCFoot infections in diabetic patients. Decision and cost-effectiveness analysesJAMA1995127397127207853629
- OyiboSOJudeEBNguyenHCHarklessLBBoultonAJA comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systemsDiabetes Care2001241848811194247
- O’BrienBEconomic evaluation of pharmaceuticals. Frankenstein’s monster or vampire of trials?Med Care199634Suppl 12DS99DS1088969318
- HabacherWRakovacIGorzerEA model to analyse costs and benefit of intensified diabetic foot care in AustriaJ Eval Clin Pract20071390691218070261
- SondikEThe optimal control of partially observable Markov decision processes over the infinite horizon: discounted costsOper Res197826282304
- GoulionisJVozikisAMedical decision making for patients with Parkinson disease under Average Cost CriterionAust New Zealand Health Policy20096151819159485
- GoulionisJMedical treatments using partially observable Markov decision processesJP J Biostat2009327797
- GoulionisJKoutsioumarisBStengosDDynamic decision making for clinical patient management with Parkinson’s diseaseJP J Biostat200823217235
- LovejoyWA survey of algorithmic methods for partially observed Markov decision processesAnn Oper Res19912814765
- Ragnason TennvallGApelqvistJPrevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulationsDiabetologia200144112077208711719840
- FosterAEdmondsMSimple staging system: a tool for diagnosis and managementDiabetic Foot200035662
- ManesCPapazoglouNSossidouEPrevalence of diabetic neuropathy and foot ulceration: identification of potential risk factors – a population based studyWounds2002141115
- DallaPFagliaECaminitiMClericiGNinkovicSDeanesiVUlcer recurrence following first ray amputation in diabetic patients: a cohort prospective studyDiabetic Care200326618741878
- BelhadjMLa place du pied diabetiqueDiabetes Metab199824Suppl 1LXVII
- RamseySDNewtonKBloughDIncidence, outcomes, and cost of ulcers in patients with diabetesDiabetes Care199922338238710097914
- BertsekasDDynamic Programming and Optimal ControlI and IIBelmont, MAAthena Scientific1995
- BoultonAVileikyteLRagnason TennvallGApelqvistJThe global burden of diabetic foot diseaseLancet20053661719172416291066
- ApelqvistJWhat is the most effective way to reduce incidence of amputation in the diabetic foot?Diabetes Metab Res Rev200016Suppl 1S75S8311054894
- OrtegonMRedekopWNiessenLCost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysisDiabetes Care20042790190715047646
- RaunerMHeidenbergerKPesendorferEModel-based evaluation of diabetic foot prevention strategies in AustriaHealth Care Manag Sci2005825326516379409